Dispatches from BIO 2016

Drug development in space: how microgravity enables pharma

The SpaceX Dragon spacecraft nears the International Space Station during the CRS-8 mission to deliver experiments and supplies to the International Space Station. (Image credit: NASA)

Eli Lilly is conducting several experiments on the International Space Station (ISS) US National Laboratory over the next year – with several implications for pharma back on Earth.

Related News

Recombinant cell lines provide cost-effective models the early stages of drug development. (Image: iStock/Artsanova)

CrownBio introduces new recombinant cell lines for oncology drug discovery

Enrollment is set to begin late this year. (Image: iStock)

Lilly, Boehringer Ingelheim collaborating on clinical trial

(Image: iStock/ajus)

Purdue Pharma joins health policy research organization

The project is titled “Developing an ethical, sustainable, human sensory neuron cell culture model for use in therapeutic pain research,” or DRGNET. (Image: iStock/bodym)

Metrion: research consortium aiming to reduce animal studies, facilitate new drug development

MR Solution’s – MRS 3017 – 3T cryogen-free MRI preclinical scanner will help advance cancer research with a focus on malignant brain tumors. (Image: MR Solutions)

Preclinical imaging system aids translational research

AAPS highlights key trends at annual meeting

AAPS highlights key trends at annual meeting

(Image: iStock/Pinkypills)

Eli Lilly taps Cogstate as preferred provider

With an increasing number of drugs that are ineligible for reimbursement, companies have to better demonstrate their product's value. (Image: iStock/VladimirFLoyd)

Exclusion lists challenging drug developers

Image: iStock/Oleksii Glushenkov

Lilly takes to continuous manufacturing with $40m Irish investment


Big pharma interest in specialty drugs will fuel US market growth says IMS Health

Drug particles, minus excess surfactant, suspended in an injectable solution. (Image: Jonathan Lovell, University at Buffalo)

New technique creates 'nearly pure drug' for injection

Related Products

See more related products